Psychological Support and Mgmt of ICU Psychosis

More documents

Recommendations

Info

Mood Stabilizer: Divalproex• RCT in nursing home 1• 6-week placebo vs. individual dose (mean serum level 45mcg/ml)• 56 subjects with dementia; 6 subjects discontinued treatment• Medically trail population• Results : trends for decreased scores on measures of agitationand psychosis, also on CGI ratings• Did not reach level of statistical significance• Sujects with higher baseline MMSE more likely to improve• Tolerability: Sedation, gastrointestinal symptoms, fallcommon• 6-week open-label extension 2• Sedaiton and falls continued to be most common side effects1. Porsteinsson AP, et al. Am J Geriatr Psychiatry. 2001;9:58-66.2. Porsteinsson AP, et al. Am J Geriatr Psychiatry. 2003;11:434-440.
MANY BEHAVIORAL SYMPTOMS FOUND IN FTD(INCLUDING IMPULSIVE DISINHIBITION,DEPRESSIVE SYMPTOMS, CARBOHYDRATECRAVING WITH WEIGHT GAIN, AND COMPULSIONS)HAVE BEEN DESCRIBED IN NONDEMENTIAPOPULATION, AMONG NONDEMENTED PATIENTS,THESE SYMPTOMS OFTEN IMPROVE WHENTREATED WITH MEDICATIONS THAT INCREASESEROTONIN ACTIVITY.
Page 1: โดยอ.นพ. นิพั
Page 6 and 7: 1. Sensory depivation (ภาวะ
Page 14: II. Delirium• Circulatory disturb
Page 18: PATIENTS WITH HIGH RISKFOR DEVELOPI
Page 24: When do symptoms require treatment?
Page 30 and 31: Special Considerations for Antipsyc
Page 32 and 33: Average Dosages for elderly Patient
Page 34 and 35: Mood Stabilizer: Divalproex• RCT
Page 38 and 39: Selective Serotonin Reuptake Inhibi

Psychological Support and Mgmt of ICU Psychosis

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?